APC anti-human S100A4 Antibody anti-S100A4 - NJ-4F3-D1,BioLegend,370006

Additional reported applications (for the relevant formats) include: ELISA Detection.

Host

Mouse

Reactivity

Human

Application

ICFC - Quality tested

Platform ID

BAB572393379

BioLegend

Headquarters

8999 BioLegend Way San Diego, CA 92121 United States

BioLegend

Contact

Tel: 1-858-455-9588
Fax: +49 (4131) 7023913

Email:

Product Specifications
Scientific Background

Specifications

NameAPC anti-human S100A4 Antibody anti-S100A4 - NJ-4F3-D1
Cat. No.370006
HostMouse
RRIDAB_2616691 (BioLegend Cat. No. 370005)AB_2616692 (BioLegend Cat. No. 370006)
IsotypeMouse IgG1, κ
ReactivityHuman
ApplicationICFC - Quality tested
ClonalityMonoclonal
Clone NumberNJ-4F3-D1
ConcentrationLot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in ourCertificate of Analysisonline tool.)
TargetS100A4
ImmunogencDNA
PurityThe antibody was purified by affinity chromatography and conjugated with APC under optimal conditions.
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
StorageThe antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light.Do not freeze.
Regulatory StatusResearch Use Only

Scientific Background

S100A4 is a member of the S100 family of calcium-binding proteins that contain two Ca2+-binding EF-hand motifs. S100 proteins are localized in the cytoplasm and/or nucleus of a wide range of cells. S100A4 interacts with cytoskeletal proteins and enhances metastasis of several types of cancer cells. It can be secreted by unknown mechanisms, stimulating a variety of cellular responses, including angiogenesis and neuronal growth. S100A4 has been shown to be a prognostic marker in a number of human cancers. It also has a potential use as a marker for tumor metastasis and disease progression.

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.